About Us

Vijai is the founder and CEO of Secure Transfusion Services. He spent nearly two decades as a life sciences institutional investor in both private equity and hedge funds, including senior positions at Arcline Investment Management and Origin Capital Management. Previously in his career, he managed corporate finance and investor relations at Onyx Pharmaceuticals, an early gene therapy pioneer. Vijai graduated with a BA in Economics and Molecular Biology, in addition to a Masters in Biotechnology from the University of Pennsylvania.

Kris is a 17-year veteran of Grifols, one of the largest plasma collection companies in the world. During his tenure, Kris held both operational and regulatory leadership positions. Most recently, as  Director of Operations, Kris was directly responsible for 46 plasma centers collecting up to 3 million liters of plasma annually while overseeing more than 2,000 employees. He earned a BS degree from Northwest Nazarene University in 2007 and an MBA from Colorado State University in 2012.

Matt has over 20 years of executive management, business development, commercial, and legal expertise in private and public life science companies. Matt is also the Chief Client Corporate Development Advisor at Wilson, Sonsini.  Matt was previously Senior Vice President of Corporate Development at Counsyl, which was acquired by Myriad Genetics in 2018, and Chief Business Officer at CareDx, which he helped take public in 2014. Matt has a BA from Cornell University and a JD from Villanova University.

Phil is the Director of the Pediatric Critical Care Translational Research Program at St Louis Children’s Hospital and Professor of Pediatrics at Washington University School of Medicine. A veteran of the Iraq War, Phil is internationally recognized as an expert in transfusion medicine and the resuscitation of hemorrhagic shock. A co-founder of the THOR Network and its Co-Director since 2011, Phil has published over 200 manuscripts and 16 chapters in the areas of pediatric and adult critical care.

Drew joined STS with over 10 years of experience at Grifols, where he held roles of increasing responsibility ranging from center director to senior leadership of a business unit.  As Manager of Process and Technology, Drew was responsible for managing business systems, standardizing processes, and introducing new technologies to the Grifols fleet of 200+ plasma collection facilities.  Drew has expertise in all facets of donor center operations and regulatory compliance, including, business system integration, process optimization, vendor relations, and new site development.

Jason has over a decade of experience in quality and regulatory management within the plasma industry. As a regional quality and regulatory affairs manager at Grifols, Jason was responsible for the quality and compliance of over 70,000 annual plasma donations. Jason brings expertise in Food and Drug Administration (FDA) 21 CFR Part 11 compliance, European Medicine Agency (EMA) regulation, Clinical Laboratory Inspection Agency (CLIA) requirements, and Plasma Protein Therapeutic Association (PPTA) guidelines. Jason has a BS in Biology from Bemidji State University.